These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 17102158

  • 1. Insulin treatment and the problem of weight gain in type 2 diabetes.
    Carver C.
    Diabetes Educ; 2006; 32(6):910-7. PubMed ID: 17102158
    [Abstract] [Full Text] [Related]

  • 2. Weight gain during insulin therapy in patients with type 2 diabetes mellitus.
    Heller S.
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S23-7. PubMed ID: 15315867
    [Abstract] [Full Text] [Related]

  • 3. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE.
    J Diabetes Complications; 2009 Sep; 23(2):143-52. PubMed ID: 18413192
    [Abstract] [Full Text] [Related]

  • 4. Early use of insulin in type 2 diabetes.
    Eldor R, Stern E, Milicevic Z, Raz I.
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S30-5. PubMed ID: 15955372
    [Abstract] [Full Text] [Related]

  • 5. Insulin-associated weight gain in diabetes--causes, effects and coping strategies.
    Russell-Jones D, Khan R.
    Diabetes Obes Metab; 2007 Nov; 9(6):799-812. PubMed ID: 17924864
    [Abstract] [Full Text] [Related]

  • 6. Failure of insulin treatment in obese patients with non-insulin-dependent diabetes mellitus.
    Fassberg J, Toffler WL, Fields SA, Loriaux LD.
    J Fam Pract; 1993 Jul; 37(1):76-81. PubMed ID: 8345343
    [Abstract] [Full Text] [Related]

  • 7. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C, Hernández Herrero C, Rivas Fernández M.
    Diabet Med; 2008 Aug; 25(8):916-23. PubMed ID: 18959604
    [Abstract] [Full Text] [Related]

  • 8. [How to minimize weight gain associated with insulin treatment].
    Philippe J.
    Rev Med Suisse; 2010 Jun 09; 6(252):1199-200, 1202-4. PubMed ID: 20614755
    [Abstract] [Full Text] [Related]

  • 9. Weight gain in type 2 diabetes mellitus--not all uphill.
    Cohen O, Norymberg C, Neumann E, Dekel H.
    Diabetes Res Clin Pract; 2008 Jan 09; 79(1):128-32. PubMed ID: 17720273
    [Abstract] [Full Text] [Related]

  • 10. Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes?
    Joffe D, Yanagisawa RT.
    Med Clin North Am; 2007 Nov 09; 91(6):1107-23, ix. PubMed ID: 17964912
    [Abstract] [Full Text] [Related]

  • 11. Does insulin detemir have a role in reducing risk of insulin-associated weight gain?
    Hermansen K, Davies M.
    Diabetes Obes Metab; 2007 May 09; 9(3):209-17. PubMed ID: 17391147
    [Abstract] [Full Text] [Related]

  • 12. Use of insulin and weight gain: optimizing diabetes nutrition therapy.
    Daly A.
    J Am Diet Assoc; 2007 Aug 09; 107(8):1386-93. PubMed ID: 17659906
    [Abstract] [Full Text] [Related]

  • 13. Diabetes medications and body weight.
    Mitri J, Hamdy O.
    Expert Opin Drug Saf; 2009 Sep 09; 8(5):573-84. PubMed ID: 19538102
    [Abstract] [Full Text] [Related]

  • 14. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA, Kane MP, Busch RS.
    Pharmacotherapy; 2007 Oct 09; 27(10):1449-55. PubMed ID: 17896900
    [Abstract] [Full Text] [Related]

  • 15. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations.
    Gottesman I.
    Diabetes Res Clin Pract; 2004 Sep 09; 65 Suppl 1():S17-22. PubMed ID: 15315866
    [Abstract] [Full Text] [Related]

  • 16. [Mechanisms for weight gain during blood glucose normalization].
    Laville M, Andreelli F.
    Diabetes Metab; 2000 Jun 09; 26 Suppl 3():42-5. PubMed ID: 10945152
    [Abstract] [Full Text] [Related]

  • 17. [Development of body weight during antidiabetic treatment].
    Hamann A.
    Dtsch Med Wochenschr; 2006 Dec 09; 131 Suppl 8():S255-8. PubMed ID: 17139582
    [Abstract] [Full Text] [Related]

  • 18. Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight.
    Bonora E.
    Int J Clin Pract Suppl; 2007 Aug 09; (154):19-28. PubMed ID: 17593274
    [Abstract] [Full Text] [Related]

  • 19. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.
    Westphal SA, Palumbo PJ.
    Arch Intern Med; 2007 Aug 09; 163(15):1783-5; discussion 1785. PubMed ID: 12912711
    [No Abstract] [Full Text] [Related]

  • 20. Patient and treatment perspectives: Revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk.
    Peters AL.
    Cleve Clin J Med; 2009 Dec 09; 76 Suppl 5():S20-7. PubMed ID: 19952300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.